Sort
25,944 grants matching “neurodegeneration”
Mechanistic dissection of a novel meiotic exit regulation by autophagy - Equipment Supplement
$198,790Fei Wang · Ut Southwestern Medical Center · R01 · FY2023 · GM
Autoimmune Mechanisms of Metabolic Dysfunction in the Central Nervous System
$198,780John Vincent Pluvinage · University Of California, San Francisco · K08 · FY2025 · NS
Glia Exclusive Gene Therapy
$198,750Or Shemesh · University Of Pittsburgh At Pittsburgh · R21 · FY2025 · EB
Immune Contribution to Brain Atrophy
$198,750Aaron J Johnson · Mayo Clinic Rochester · R21 · FY2017 · NS
Mitochondrial dysfunction in ALS
$198,750Univ Of Massachusetts Med Sch Worcester · R01 · FY2003 · NS
Brain organoid modeling of Gaucher disease for identification of pathogenic pathways and therapy development
$198,750Ying Sun · Cincinnati Childrens Hosp Med Ctr · R21 · FY2021 · HD
Neuroinflammation induced by mild viral encephalitis during young adulthood accelerates tauopathy-mediated neurodegeneration later in life.
$198,750Charles Lee Howe · Mayo Clinic Rochester · R21 · FY2019 · NS
Immunosuppression in humans with AD
$198,750Carol A Colton · Duke University · R21 · FY2016 · AG
The epichaperome: A novel therapeutic target for traumatic brain injury
$198,750C Edward Dixon · University Of Pittsburgh At Pittsburgh · R21 · FY2025 · NS
Regulating mtDNA and mtRNA dynamics by the mitochondrial AAA+ Lon protease
$198,750Carolyn K Suzuki · Rbhs-New Jersey Medical School · R21 · FY2017 · HD
Novel 3D brain tissue-based screening assay for targeting microglia in CNS neurodegeneration
$198,750Donald C Lo · Duke University · R21 · FY2017 · NS
Biomarker discovery for juvenile neuronal ceroid lipofuscinosis
$198,750David Edward Sleat · Rbhs-Robert Wood Johnson Medical School · R21 · FY2015 · NS
Glia Exclusive Gene Therapy
$198,750Or Shemesh · University Of Pittsburgh At Pittsburgh · R21 · FY2024 · EB
Neurovascular frataxin and cognitive dysfunction in sickle cell disease
$198,750Rimi Hazra · University Of Pittsburgh At Pittsburgh · R21 · FY2024 · NS
PAPP-A as a Potential Target in Alzheimer's Disease
$198,750Cheryl A Conover · Mayo Clinic Rochester · R21 · FY2023 · AG
Neuropathology and Optical Imaging Core
$198,749Howard Brent Clark · University Of Florida · P01 · FY2010 · NS
SCREENING FOR DRUGS IN A DROSOPHILA TRANSGENIC MODEL
$198,704University Of California Los Angeles · P50 · FY2005 · AG
Deciphering RNA based mechanisms of neurodegeneration
$198,559Daniela C Zarnescu · University Of Arizona · R21 · FY2012 · NS
A TOXIN BASED DROSOPHILA PARKINSON'S DISEASE MODEL
$198,515Cambria Biosciences, Llc · R43 · FY2005 · ES
Immunoprofiling postoperative delirium during aging and neurodegeneration
$198,489Harris A Gelbard · University Of Rochester · R21 · FY2022 · AG
Pursuing purine pathways to clinical trials for Parkinson's disease
$198,486Michael A Schwarzschild · Massachusetts General Hospital · K24 · FY2012 · NS
Serotonin Modulation of Neural Circuitry in bvFTD: Understanding the Neurobiology of Mood and Cognitive Symptoms
$198,355Christopher B. Morrow · Johns Hopkins University · K23 · FY2024 · AG
Identification of plasma hydroxysphingolipids as biomarkers of demyelination and neurodegeneration underlying physical function decline in older adults
$198,334Danni Li · University Of Minnesota · R21 · FY2019 · AG
Mitochondrial dysfunction in ALS
$198,334Univ Of Massachusetts Med Sch Worcester · R01 · FY2002 · NS
The mediating role of Slow Wave Sleep and Vascular Risk Factors on Alzheimer Disease related disparity between African-Americans and non-Hispanic Whites
$198,325Omonigho A Michael Bubu · New York University School Of Medicine · K23 · FY2021 · AG